Driving research of Myalgic Encephalomyelitis / Chronic Fatigue Syndrome (ME / CFS),
Post Treatment Lyme Disease Syndrome (PTLDS), Fibromyalgia and Post COVID .

Photo by King of Hearts
Wikimedia Commons

ME/CFS Collaborative Research Centre
at Stanford University

Innovative, collaborative, open-data research to end Myalgic Encephalomyelitis / Chronic Fatigue Syndrome (ME / CFS)


What we hope to achieve


Our fundamental philosophy


List of scientific collaborators

Research Studies

Current research projects

About the research centre

The ME/CFS Collaborative Research Centre (previously known as the CFS Research Centre) at Stanford University was established in 2014 and is part of the Stanford Genome Technology Center. Both centres are directed by Ronald W. Davis, PhD, Professor of Biochemistry and of Genetics at Stanford.

 Director: Ronald W. Davis, PhD

Throughout his career, Dr. Davis has conducted cutting edge, innovative, interdisciplinary research and technology development on cancer, immunology, genetics, infectious disease, novel drug development, and nanofabrication of diagnostic instruments. His emphasis has always been to increase accuracy and decrease cost. He has made significant contributions to research on numerous organisms, including bacteria, yeast, plants and humans.

Dr. Davis was the first to physically map the genome of any organism (1968).

Dr. Davis discovered a simple way to join together DNA from two organisms (“sticky ends”), and was the first to generate a hybrid DNA molecule that could replicate inside of cells (DNA cloning).

He developed most of the technology for the molecular genetics of yeast, which made it the most advanced model for conducting molecular genetics research.

Read More

Core Aims

Fundamental Philosophy

Current Studies

Severely iIl Patient

Severely ill Patient Study STUDY AIM The aim of the Severely Ill Patient Study (SIPS), which started in 2015, was to conduct a comprehensive “Big …

Read More →
T cells and Immunology

T cells and Immunology STUDY AIM Beginning in 2016, the aim of this study was to establish the role of T cells and the immune …

Read More →
Extended Big Data Study in Families

Extended Big Data Study in Families STUDY AIM Beginning in 2016, the aim of this study was to extend the Severely ill Patient Study (SIPS) …

Read More →

Developing Technology

Developing blood-based diagnostic and drug screening technology

There is currently no biological test to diagnose Myalgic Encephalomyelitis / Chronic Fatigue Syndrome (ME / CFS) and as a result, diagnosing patients is a lengthy and costly process, constituting a fundamental impediment in patient care. This lag in diagnosis also erects barriers to research, complicating patient recruitment and potentially engaging a heterogeneous sample of patients with only superficially similar conditions.

Dr. Davis’s team is dedicated to developing inexpensive tests that can be easily used in a doctor’s office.  Patients will be measured on multiple diagnostic platforms, enabling  comparisons of efficacy to determine what combination of platforms would be most useful  for diagnostic testing.

Nanoneedle Diagnostic Tool

Developing Nanoneedle Technology TECHNOLOGY VALUE The technology will be optimized for easy clinical adoption and scaled up so that numerous FDA-approved drugs can be simultaneously …

Read More →
Red Blood Cell Deformability

Red Blood Cell Deformability in ME/CFS TECHNOLOGY VALUE This work has been accepted for publication in Clinical Hemorheology and Microcirculation and also has been accepted …

Read More →
Magnetic Levitation Platform

Magnetic Levitation Platform TECHNOLOGY VALUE This could be a very inexpensive and effective diagnostic test for ME/CFS. LEAD INVESTIGATORS Gozde Durmus, PhD Ronald W. Davis, …

Read More →
Mitochondrial Function Test

Mitochondrial Function Test TECHNOLOGY VALUE Demonstrates a significant difference between ME/CFS patients and healthy controls. LEAD INVESTIGATORS Julie Wilhelmy, SGTC Ronald W. Davis, PhD UPDATES …

Read More →
To carry out this ambitious work, Dr. Davis has assembled a team of extraordinary scientists with expertise in a wide variety of areas directly relevant to Myalgic Encephalomyelitis / Chronic Fatigue Syndrome (ME / CFS) research.


Ronald W. Davis, PhD, Professor of Biochemistry and Genetics, Stanford University School of Medicine; Director, Stanford Genome Technology Center; Director, Chronic Fatigue Syndrome Research Center at Stanford University; Chair, Open Medicine Foundation ME/CFS Scientific Advisory Board.

Collaborative Research Centre / Stanford Genome Technology Centre
Robert Phair, PhD

Wenzhong Xiao, PhD

Mohsen Nemat-Gorgani, PhD

Peidong Shen, PhD

Laurel Crosby, PhD

Michael Jensen

Fereshteh Jahaniani, PhD

Gozde Durmus, PhD

Julie Wilhelmy

Alex Kashi

Anand Ramasubramanian, PhD

Amit Saha, PhD

Layla Cervantes

Ami Mac, MD

David Kaufman, MD

Bela Chheda, MD

Chris Armstrong, PhD

Katrina Hong

Anna Okumu

Ashley Haugen

Juan Santiago, PhD

Eric Shaqfeh, PhD

Mark M. Davis, PhD

Michael Sikora

Mike Snyder, PhD

Craig Heller, PhD

Lars Steinmetz, PhD

Jonas Bergquist, MD, PhD

Rahim Esfandyarpour, PhD

Ron Tompkins, MD, ScD

Curt Scharfe, MD

Robert Naviaux, MD, PhD

William Robinson, MD

Lucinda Bateman, MD

Jennifer Frankovich, MD

Learn about Our Other OMF Funded Collaborative Research Centres